Creatine while breastfeeding is a searched question with an unusual shape: the baseline is measured and the intervention is not. Creatine is a normal constituent of human milk. What a supplemental dose does to that level has never been measured in a human. This page reports what the lactation record contains, who has published a position and when, and nothing beyond that — decisions about a nursing infant belong with a clinician, as this site's editorial standards commit it to saying.
The national body's record, and its date
The Drugs and Lactation Database (LactMed), maintained by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, carries a creatine record last revised 2025-07-15. It is short, and every clause in it is a separate fact:
- Creatine is a normal component of human milk, supplying about 9% of the infant's daily requirement, with the amount varying by country and ethnicity.
- Levels are highest in colostrum, decreasing over the first two weeks postpartum before stabilising.
- "Milk levels of creatine have not been measured after supplementation in humans."
- Creatine blood levels are lower in vegan than omnivorous mothers.
- Some authors have speculated that supplementation of nursing mothers might help avoid creatine deficiency syndromes, but no studies are available that test this hypothesis.
- Creatine converts to creatinine in mother and infant, and can increase the infant's serum creatinine, which may alter estimations of the infant's kidney function.
- Its position: "Until more data are available, it is probably best to avoid creatine supplementation unless it is prescribed by a healthcare professional."
That last line is a national body's published position and is quoted here as one, with its revision date attached. This page does not add to it, soften it, or argue with it.
The measured baseline, and how small it is
The strongest primary data on creatine in milk comes from a 2024 study in Nutrients, and its scale should be stated before its findings: 10 mothers, followed longitudinally across the first six months of breastfeeding, plus umbilical arterial and venous cord blood from 10 term infants after elective caesarean.
What it found:
- Milk creatine highest in colostrum, falling significantly within the first two weeks (p < 0.05), and not changing significantly thereafter.
- Milk creatine not correlated with milk creatinine or with macronutrient composition — so it cannot be predicted from the fat, protein or lactose content of the same sample.
- A mean fetal creatine flux of −2.07 mmol/min at the end of pregnancy, from which the authors conclude that fetal endogenous synthesis covers fetal needs at term.
- Their own hypothesis from the pattern: the high colostrum concentration suggests a demand immediately after birth that enteral supply covers.
Twenty people. It is the best description available of what is normally there, and it is a study small enough that its authors present its conclusions as suggestions.
One thing worth noticing in the author list, because the reader cannot see it from a summary: the paper's declared interests include an employee of Alzchem Trostberg, the manufacturer behind the Creapure creatine brand this site covers on Creapure explained, and a researcher at Danone Nutricia Research, an infant-formula company. Both are declared in the paper, which is the system working. It is still the case that the main description of creatine in breast milk was co-authored by a creatine manufacturer and a formula manufacturer, and a reader is entitled to hold that alongside the findings.
The trials that do not exist
Searched on 2026-09-20: creatine[tiab] AND (breastfeeding[tiab] OR lactation[tiab] OR "breast milk"[tiab]) returns 116 records, of which two carry the clinical-trial publication type.
Read individually, the two are a metritis vaccination study in Holstein dairy heifers and a urinary metabolomics study of a probiotic strain in women with mastitis, in which creatine appears as a metabolite in a urine profile. Neither administers creatine to anyone.
Following the rule this network applies to any zero, it was checked against a query known to return something: the same search without the trial filter returns 116, and the underlying database returns 1,151 records for creatine supplementation generally. The search works; there is no trial.
The distinction the whole page turns on
Two sentences, both true, that are constantly merged:
- Creatine is a normal component of breast milk, supplying roughly 9% of an infant's requirement.
- Nobody has measured what a supplemental dose does to it.
The first describes a baseline that exists whether or not anyone supplements. The second is the question being asked. A substance being endogenous and dietary is a fact about biology and not an argument about supplements — the same boundary this site holds on creatine in pregnancy, where the identical slide is the commonest error in the topic.
The infant-creatinine point is the concrete version of why the gap matters. It is not a claim that anything is harmed; it is a claim that a number a clinician might rely on could move. This site has set out at length, on creatine and kidneys, how creatine supplementation shifts the creatinine marker in adults without the tracer-measured filtration rate changing. The same arithmetic applied to an infant's blood test is a reason for a clinician to know what a mother is taking, which is precisely the reasoning behind LactMed's stated position.
The honest summary
- Creatine is normally in human milk, about 9% of an infant's daily requirement, highest in colostrum.
- No human study has measured milk creatine after supplementation. LactMed says so in those words.
- LactMed's position, revised 2025-07-15: probably best to avoid supplementation unless prescribed by a healthcare professional.
- The measured baseline literature is 10 mothers and 10 infants, co-authored by a creatine manufacturer and a formula manufacturer, both declared.
- The two clinical-trial-tagged records in this area are about dairy heifers and mastitis probiotics.
- Creatine converts to creatinine and can raise an infant's serum creatinine, altering kidney-function estimates.
Limits of this page
The census is a title-and-abstract classification of one database on one date. The milk-composition data rest on a single small study whose author list carries declared commercial interests in both creatine and infant nutrition. LactMed is a curated evidence summary, not a systematic review, and its position statement is an editorial judgment by that body which it may revise. Nothing here is medical advice, a recommendation, or a reason to start, continue or stop anything while breastfeeding. A question about a nursing infant requires a clinician who knows the case; this page describes what the published record contains and no more.
Sources and dates
- Creatine. In: Drugs and Lactation Database (LactMed). Bethesda (MD): National Institute of Child Health and Human Development; 2006–. Record revised 2025-07-15 — PMID 30000913
- Mihatsch WA, Stahl B, Braun U. The umbilical cord creatine flux and time course of human milk creatine across lactation. Nutrients 2024;16(3):345 — PMID 38337631
- PubMed, searched 2026-09-20:
creatine[tiab] AND (breastfeeding[tiab] OR lactation[tiab] OR "breast milk"[tiab])— 116 records; with"clinical trial"[pt]— 2, classified individually above.
